What's New in Clinical ink Early Look
2.6.2
October 18, 2024
This release addresses several bug fixes and performance improvements.
Alternatives to Clinical ink Early Look
More Applications by Clinical Ink, Inc
FAQ
Can Clinical ink Early Look be used on iPad devices?
No, Clinical ink Early Look can’t be used on iPad devices yet.
Who launched the app?
Clinical Ink, Inc is the developer of the Clinical ink Early Look app.
What minimum version of iOS does Clinical ink Early Look need?
The minimum iOS requirement for the app is 11.0 or higher.
What do users think of the Clinical ink Early Look app?
No ratings have been provided for the Clinical ink Early Look app so far.
What category of app is Clinical ink Early Look?
The Clinical Ink Early Look App Relates To The Health & Fitness Genre.
What is the recent version of the Clinical ink Early Look app?
2.6.2 is the newly released Clinical ink Early Look version.
When was the most recent Clinical ink Early Look update made available?
January 5, 2025 is the exact date of the latest Clinical ink Early Look update.
Do you know when Clinical ink Early Look was first made available?
The Clinical ink Early Look app became available to the public on February 5, 2023.
What age is Clinical ink Early Look suitable for?
Clinical Ink, Inc: The Clinical ink Early Look app is child-friendly.
What are the languages offered by the Clinical ink Early Look app?
Clinical ink Early Look can be used in American English, Afrikaans, Arabic and 46 more.
Is Clinical ink Early Look accessible through Apple Arcade's subscription model?
Unfortunately, Clinical ink Early Look is not on Apple Arcade.
Does Clinical ink Early Look allow for in-app purchases?
No, Clinical ink Early Look does not allow for in-app purchases.
Is Clinical ink Early Look specifically engineered for Apple Vision Pro compatibility?
Sorry, Clinical ink Early Look is not specifically engineered for compatibility with Apple Vision Pro.
Does Clinical ink Early Look display any ads?
No, Clinical ink Early Look does not display any ads.